• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Skip to navigation
Close Ad

The Spoon

Daily news and analysis about the food tech revolution

  • Home
  • Podcasts
  • Events
  • Newsletter
  • Connect
    • Custom Events
    • Slack
    • RSS
    • Send us a Tip
  • Advertise
  • Consulting
  • About
The Spoon
  • Home
  • Podcasts
  • Newsletter
  • Events
  • Advertise
  • About

Shiok Meats

August 10, 2021

Shiok Meats Acquires Gaia Foods, Will Add Beef to Its Cultured Meat Lineup

Shiok Meats, a company best known for its developments in cultured seafood, has acquired a 90 percent steak in Gaia Foods, according to Tech in Asia, which broke the news. Financial terms of the deal were not disclosed.

Through the deal, Singapore’s Shiok Meats will add “a variety of red meat products” to its roster, since the company will be able to draw on Gaia Foods expertise in developing cultured beef. Gaia, also based in Singapore is also developing cultured pork and mutton.

Both companies are targeting markets in Asia, including Singapore, Malaysia, Indonesia, China, Japan, Taiwan, India, and South Korea. Shiok Meats hopes to blend cultured beef and shrimp in order to create a product that can be used in a variety of dishes, from dumplings and noodles to spring rolls.

Shiok raised an undisclosed round of bridge funding last month that will go towards building out a production facility in Singapore. The company said at the time of the funding that it plans to launch commercially in that market by 2023 at the latest. Speaking to Tech in Asia today, company CEO Sandhya Sriram said Shiok Meats is ready to “power through to commercialization.”

Singapore is currently the only country in the world that has granted regulatory approval to sell cultured meat, and to just one company, Eat Just. Gaining its own approval — in Singapore and elsewhere — will be a major next step for Shiok on its path to commercialization. 

Beyond regulatory approval, Shiok Meats and every other company developing cultivated meat has a host of challenges to contend with before consumers can buy their products en masse at restaurants and grocery stores. Those challenges span everything from making cell lines more available to finding cheaper, less ethically hazy growth mediums, and educating the average consumer about what cultured meat actually is and why we need to consider it as a protein source in the first place.  

Gaia founders Vinayaka Srinivas and Hung Nguyen will lead the Shiok Meats technical team’s development process for cultured red meat products for the company moving forward. Meanwhile, Sriram told Tech in Asia that deals like this one will become “priorities” in the near-term future for the company.

July 21, 2021

Shiok Meats Closes Bridge Funding Round, Plans R&D Facility for Cultivated Seafood

Cultured seafood company Shiok Meats has raised an undisclosed amount of investment in a bridge funding round from Woowa Brothers Asia Holdings, CJ CheilJedang Corporation, and Vietnamese-based seafood exporter Vinh Hoan Corporation. This brings Shiok Meats’ total funding to date to $30 million, according to a company press release. 

The round also included existing investors IRONGREY, Big Idea Ventures, Twynam Investments, Henry Soesanto, The Alexander Payne Living Trust, Beyond Impact Vegan Partners, Boom Capital Fund, Toyo Seikan Group Holdings, and Mindshift Capital.

While Shiok Meats did not disclose the exact amount of the bridge round, it likely clocked in around the $10 million mark, a figure based on publicly available information about the company’s financials.  

The new funds will go towards building an R&D production facility in Singapore, where the company is based. To date, Shiok Meats has developed cultivated shrimp and lobster, and aims to eventually produce those products at scale via its production facility.

Several other cultivated protein companies, including Future Meat, MeaTech 3D, and fellow cultured-seafood company Willdtype, have also announced production facilities over the last few months. BlueNalu, another seafood-focused company, announced a production facility back in 2020 that is slated to be operational towards the end of this year.

For its part, Shiok Meats says it plans to launch in Singapore by 2023 at the latest. The company received the prestigious Startup SG Tech Proof-of-Value grant, which helps companies fast-track development of their technologies/products and which could help Shiok Meats get to market faster.

In Singapore, at least, Shiok already has competition. San Francisco, California-based Eat Just nabbed the world’s first-ever regulatory approval to sell cultivated meat from Singapore and is currently selling its “chicken” at restaurants in the city-state.   

November 23, 2020

Shiok Meats Unveils Prototype for Cell-Based Lobster

At a recent exclusive tasting event, Singapore-based Shiok Meats unveiled a prototype for cell-based lobster, according to FoodNavigator-Asia, who attended the event. The prototype was unveiled at the event as part of two dishes, a lobster gazpacho and lobster terrine.

Shiok said the lobster is cultivated with the same technology the company uses it make its cell-based shrimp. Shiok takes a sample of lobster cells, which are then grown in a bioreactor and harvested several weeks later. Right now, it takes between four and six weeks for Shiok to produce its cell-based shrimp; the company says the lobster takes a couple weeks longer than that. It is also more expensive to produce, though the company is looking to bring the cost down to $50/kg at some point in the future.

Neither the shrimp nor the lobster are available for sale to consumers right now. The company plans to have its Shiok Shrimp product commercially available by 2022. A manufacturing plant in Singapore is slated to be operational at that time, too. Shiok raised a $12.6 million Series A round in September of this year, part of which will go towards building out the production facility. FoodNavigator reported that once that plant is up and running, Shiok will be able to get regulatory approval to sell its products, which it will initially do in restaurants and other B2B settings.

No cell-based meat or seafood is currently available for commercial sale, though plenty of companies are moving towards that future. The list includes BlueNalu, a company that also makes cell-based seafoods and is currently expanding its production facility, which the company plans to open in the next five years. And plenty of investment is currently happening in the cell-based meat sector, with Mosa Meat, Integriculture, Meat-Tech 3D, and others all raising funding in the last six months.

However, being able to sell these products to mainstream consumers and at scale will be a much longer process, one that could take up to 15 years, by some accounts. Costs must first come down, and companies must get regulatory approval before they can even sell their products to restaurants.

For its part, Shiok will keep innovating on various cell-based seafoods in the meantime. In addition to shrimp and lobster, the company plans to introduce a cell-based carp prototype in a few months. 

October 15, 2020

SKS 2020: Why Singapore Is Fast-Becoming Food Tech’s New Superpower

That Singapore is a fast-rising superpower in food tech is something that’s become apparent over the last several months. And yesterday, during a SKS 2020 panel on the Asian food tech landscape, the city-state came up in conversation again as an enormously important location to watch when it comes to food innovation and investment.

“If I had to place my bet I would place it on Singapore,” said Michal Klar, an angel investor who also writes the Future Food Now newsletter. Joining him on the panel were Winnie Leung of Bits x Bites and Spoon Publisher Mike Wolf, and together, the group unpacked some of the reasons why so much food tech innovation is coming out of Singapore right now.

Arguably the biggest driver is that, at the moment, Singapore imports 90 percent of its food. That’s a precarious position to be in during the best of times, never mind during a pandemic that’s disrupted the global food supply chain. In response, the Singapore government launched a $21 million grant fund this year as part of its 30×30 initiative, which aims to have 30 percent of Singapore’s food produced locally by 2030. 

At the same time, that reliance on imports for the majority of its foods may actually help Singapore innovate on food tech faster for the short term. Since so much of the city-state’s food comes from outside its own borders, Singapore lacks some of the constraints other countries face when it comes to getting pushback by established players.

Alternative protein is a good example. Here in the U.S., both plant- and cell-based meat companies must go toe-to-toe with Big Meat producers and lobbyists over labeling of their products, shelf placement, and other issues. By contrast, Klar suggested that because Singapore’s meat supply is imported there’s nobody to push back on new developments and regulations happening in the city-state around alternative forms of meat. That, Klar reasoned, is one of the reasons Singapore is home to Asia’s best-funded cell-base meat startup, Shiok Meats, as well as a number of other up and coming players.  

Indoor agriculture/vertical farming is another area that could potentially thrive because of a lack of existing incumbents. Last year, local farms produced just 14 percent of leafy vegetables consumed by Singaporeans, so there’s little in the way of traditional agriculture to disrupt. At SKS, Leung noted that Singapore’s “highly urbanized” environment makes it an ideal setting for high-tech innovations in indoor farming. We’ve seen this in recent months with companies like SinGrow, which is growing a proprietary breed of strawberries in its vertical farm, and ag tech accelerators like GROW. Leung also flagged aquaculture as a sector to watch in Singapore.

Both Klar and Leung also pointed to Singapore’s regulatory environment as a reason for the city-states speedy growth in food tech innovation. There is only one agency in Singapore that regulates foods, said Klar. In other words, when companies prepare for the phase in which they must get government approval for their products, there’s no doubt or confusion as to who they must go to. This could speed up the process of regulatory approval, which in turn would mean a faster time to market for many companies. 

The above factors are just a smattering of reasons for Singapore food tech’s continued growth, and over the next several months we will continue to see new advances in ag tech, alt protein, packaging, and other areas of the food supply chain emerge.

October 1, 2020

The Food Tech Show: Amazon Intros Palm-Pay, Bear’s New Servi Robot

This week the Spoon team got together to talk about yet another potentially controverisal bit of palm reading tech from Amazon and other news from around the food tech world, including:

  • Bear intros their next-generation front-of-house server bot, Servi 
  • Shiok gets more funding for its lab-grown shellfish 
  • A new water vessel that kills germs with UV light
  • A Preview of the finalists for the Smart Kitchen Summit’s Startup Showcase finalists

As always, you can get the Food Tech Show on Apple Podcasts, Spotify or wherever you get your podcasts. You can also download the episode directly to your device or just click play below.

September 29, 2020

Singapore’s Shiok Meats Raises $12.6M in Series A Funding

Cell-based seafood maker Shiok Meats announced today it has raised $12.6 million in Series A funding. The round was led by Aqua-Spark, an investment fund focused on sustainable aquaculture. SEEDS Capital, Real Tech Fund, Irongrey, and several others also participated in the round, according to a press release sent to The Spoon. This brings Shiok Meats’ total funding so far to $20.2 million.

Shiok Meats said it will put the new funds towards building its commercial pilot plant, from which the company plans to launch its minced shrimp product in 2022. 

Shrimp is one of the most widely consumed seafood types in the world. For now, at least, Shiok Meats says it is the only company in the world creating a cell-based version that’s grown outside the animal. The company’s process involves isolating stem cells from the shrimp then growing them inside nutrient-rich bioreactors. 

It joins a growing list of cell-based protein producers that have raised funds over the last year, including Blue Nalu, Good Catch, and Wild Type.

For all of these companies, price remains a major hurdle to getting products to market: cell-based protein is simply an expensive process right now that makes it impossible to get products to price parity with traditional seafood offerings. On its own website, Shiok meats notes that a limited production scale is in part responsible for the high costs of its cell-based shrimp. Scaling up production will help the company bring down costs.

Shiok recently partnered with IntegriCulture to use the latter’s CultNet System to create shrimp cell cultures. Doing so brings down the overall cost of cell-based shrimp production, since it doesn’t require expensive animal serums normally used for the process. 

Shiok did a first public taste testing of cell-based shrimp dumplings last year, to positive reviews. The rest of us will have to wait a little longer. The company’s initial products will be frozen cell-based shrimp meat for dumplings and other shrimp-based dishes. In the coming years, the company also plans to launch shrimp flavoring pastes and powders, fully formed 3D shrimp, and cell-based lobster and crab products.

July 30, 2020

As Cell-Based Protein Becomes a Reality, What to Call it Gets Increasingly Important

Last week we briefly covered news about a Rutgers study that found “cell-based” the best descriptor for lab-grown seafood products. Further thought and reading on the matter leads me to believe the study’s findings have implications for labeling across all of the cell-based protein space, not just seafood.

Here’s a quick recap: A new study by Rutgers in the Journal of Food Science recommends “Companies seeking to commercialize seafood products made from the cells of fish or shellfish should use the term ‘cell-based’ on product labels.”

The study, commissioned by cell-based seafood company BlueNalu, claims to be the first of its kind evaluating how to label alternative seafood products in a way that both appeals to consumers and meets regulatory requirements around product naming. The study was done by William Hallman, a professor who chairs the Department of Human Ecology at Rutgers-New Brunswick’s School of Environmental and Biological Sciences. He noted this week that participants in the study were able to tell the label “cell-based” apart from ones like “wild caught” or “farm raised,” and that those participants still believed the cell-based products were as nutritious as the others. 

Other names tested in the study were “cell-cultured seafood” and “cultivated seafood,” as well as phrases like “cultivated from the cells of ____” and “grown directly from the cells of ____.”

It’s not hard to understand why “cell-based seafood” resonates the most with consumers. The above phrases lack the kind of concise description needed for food products, and terms like “cultivated seafood” are rather muddy in terms of describing what goes into making the product. 

This question of labeling is only going to get bigger as cell-based proteins move further from concept and into a culinary reality for average consumers. We’ve already seen this play out to some degree with plant-based proteins. About a year ago, large meat corporations were pushing hard to ban their plant-based counterparts from using words like “burgers” and “sausages” on packaging. As we wrote previously, “Big Meat trying to quash alterna-meats’ popularity by telling companies how they can or can’t label themselves feels protectionist and ineffective, not to mention desperate, at this point.” 

And that was before the pandemic. Since COVID-19 hit and shed an uncomfortably bright light on issues in traditional meat production, demand for alternative proteins has been through the roof. Just this week, investment network FAIRR released a report stating investment in alt-protein for the first half of 2020 is nearly double the amount for all of 2019. That includes cell-based protein.

Whether Big Seafood pushes back on labeling now that more cell-based seafood is coming to market remains to be seen. It will certainly have a lot of opponents if it does. BlueNalu just announced a new facility designed for commercial production of its alt-seafood products. Wild Type raised a $12.5 million Series A round last year for its cultured salmon, and Shiok Meats just partnered with Integriculture to scale up production of lab-grown shrimp. And those are only the seafood-focused players in the cell-cultured protein space.

Big Seafood aside, effective labeling of all these products — and all cell-based protein products, really — will be key to appealing to new consumers who may not have previously known about cell-based meat and dairy, and that it’s just as nutritious as the real deal. When it comes to finding a name for these alt-protein items, that could be the most difficult and most rewarding challenge companies face.  

July 7, 2020

IntegriCulture and Shiok Meats Partner to Scale Up Production of Lab-Grown Shrimp

Cell-based meat companies Integriculture and Shiok Meats announced this week that they have officially entered into a collaboration to scale up production of the latter’s cell-based shrimp, according to Vegconomist.

For the partnership, Integriculture will provide its CultNet System, which allows other businesses to culture their own animal tissues. In this case, Shiok Meats will use the CultNet System to create shrimp cell cultures. Doing so would bring the overall cost of producing lab-grown shrimp down because the system doesn’t require animal serums, which are extremely expensive, not to mention controversial.

Dr. Sandhya Sriram, co-founder of Shiok Meats, told Vegconomist that at this point, most cell-ag companies are looking for alternatives to serum, as animal serums are “neither ethical nor sustainable.” 

IntegriCulture’s CultNet System lets cell-based meat produce bypass animal serums altogether. (This democratization of meat production is one of the reasons the company landed on our Food Tech 25 list for this year.)

Unfortunately, your average consumer won’t be able to taste this cell-based shrimp yet. The companies did not give a timeline for this cell-based shrimp, and cell-based meat in general is still some time away from landing in the consumer market. IntegriCulture has said it will launch its first product, a cell-based foie gras, in 2021. Shiok Meats did its first public taste testing, of its cell-based shrimp dumplings in the spring of 2019, but the company is still most likely three to five years out from commercializing anything.

Both companies recently raised money. Integriculture raised $7.4 million this past May. Shiok Meats raised $3 million in bridge funding at the end of June.

The cultured meat and cell-ag space overall has seen much activity of late in terms of both new funding and expanding production. Memphis Meats raised $161 million at the beginning of 2020, doubling global investment in cultured meat. BlueNalu announced in June it will expand its facilities to bring cell-based seafood to test markets. Both Turtle Tree Labs and BIOMILQ have raised money for their cultured human breastmilk. 

While we’re still a ways away from grabbing cell-based meat off our grocery store shelves (or growing it at home), the flurry of new developments and funding news in this space make clear that cell-based ag is less the stuff science fiction now and inching closer to reality.

October 30, 2019

Shiok Meats Nets $500K Investment from Agronomics for Cultured Shrimp

Yesterday Agronomics, a company which invests in animal product alternatives, announced that it had completed a subscription of $500,000 in the form of a convertible loan to cell-based seafood company Shiok Meats (h/t StockMarketWire). Agronomics stated that on conversion, the subscription is expected to own a roughly 2.3 percent share in the Singaporean startup. The loan will convert to shares upon completion of a Series A funding round of $10 million by Shiok Meats.

The Singaporean company raised $4.6 million in April of this year. This latest round of investment brings its total funding to $5.3 million.

Founded in 2018, Shiok Meats is developing seafood — specifically crustaceans — outside of the animal using a technology called cellular aquaculture. Its first product is cell-based shrimp. The company did the first public taste test of its crustaceans back in March, to reportedly positive reviews.

Shiok Meats is one of several companies developing cultured seafood. Wild Type is developing cell-based salmon, BlueNalu has chosen mahi-mahi as its first cultured seafood product, and Finless Foods has stated it will bring its cell-based bluefin tuna to market over the next few years.

However, Shiok Meats is unique in two ways. Firstly it’s focusing on shrimp, which is one of the most widely consumed kinds of seafood in the world (and the number one most consumed in the U.S.) They’re also one of the few cell-based meat (or seafood) companies based in Asia, despite the fact that that’s the area of the world where cultured meat will likely make its market debut.

When I spoke with Shiok Meat’s CEO Dr. Sandhya Sriram back in January, she told me that the company is still likely 3-5 years from commercializing its first product. But with an additional half a million in its pocket, the startup is edging a lot closer to that goal.

April 29, 2019

Shiok Meats Raises $4.6M for Cell-Based Shrimp

Shiok Meats isn’t so shrimpy anymore. The Singapore-based cultured meat startup, which has been using cellular aquaculture to grow crustaceans in a lab, just completed a $4.6 million seed round (h/t Forbes).

The round sports a pretty impressive list of investors, including the CEO of Monde Nissan (owner of popular plant-based meat product Quorn). Big Idea Ventures, a new venture fund focused on meat alternatives with backing from Tyson, also participated.

This news comes just a few weeks after the startup held the first public taste-test of its shrimp. The cell-based crustaceans were tucked into dumplings and served at The Disruption in Food and Sustainability Summit (DFSS) on March 29th.

For such a young company, Shiok Meats has been quickly gaining traction and notoriety. According to its CEO and co-founder Dr. Sandhya Sriram, Shiok Meats is the first cell-based meat company based in Asia. It was also the first cultured meat startup accepted into the prestigious Y Combinator.

When we first wrote about Shiok Meats back in January, we were optimistic that their choice of location — that is, Asia — would serve them well. Not only is there far smaller competition than in, say, Silicon Valley, but Asia also has a huge appetite for alternative protein, as well as the regulatory flexibility to bring new edible technologies, like cell-based meat, to market before the U.S. does.

Clearly, investors see the opportunity as well. Forbes reports that Shiok will use its new funding for R&D and to grow its bioengineering team. Next, the company will focus on scaling so that they can have a product to market in two to three years.

March 15, 2019

Shiok Meats is First Cultured Meat Company Accepted into Y Combinator

Famed startup accelerator Y Combinator just announced the 23 companies joining its newest YC Winer 2019 batch. Among them is Shiok Meats, a Singapore-based startup developing cell-based crab and shrimp, and the first cell-based meat company to join Y Combinator.

Though they’ll be in the Bay Area to participate in Y Combinator, co-founder Dr. Sandhya Sriram told The Spoon earlier this year that they’re planning to roll out their products in Southeast Asia, specifically Singapore, Hong Kong, and India. They expect to have their first cell-based product to market in three to five years.

Y Combinator has previously invested in plant-based meat companies like Seattle Food Tech. Last summer the accelerator even included the Good Food Institute, a non-profit promoting the growth of meat alternatives, both plant-based and cell-based.

However, by letting a cultured meat company through its hallowed doors, Y Combinator is now blessing cell-based meat as a viable investment opportunity. And a blessing from the accelerator that backed AirBnB and Dropbox, among other cash cow companies, is likely going to make clean meat even more of an investment magnet than it already is.

It’s interesting that Y Combinator chose Shiok Meats as the first cell-based meat company to join their ranks, since I’m betting they’re not the first to apply. Applications can be a crapshoot and all that, but perhaps the accelerator was convinced to accept the Singaporean startup because they were convinced, as I was, that Shiok Meat’s plan to launch in Southeast Asia means that it could have a greater global impact than cultured meat companies in the U.S. or Europe.

In any case, hopefully Y Combinator’s investment and mentorship will help Shiok Meats get cell-based shrimp dumplings on our plates even sooner. In fact, the startup already has a product ready for taste testing. Shiok Meats will be hosting a tasting of dumplings made with its cell-based shrimp later this month at the Disruption in Food and Sustainability Summit in their home country of Singapore.

January 16, 2019

Shiok Meats is The First Cell-Based Meat Company in Southeast Asia

If you’ve been on the internet in the past, oh, year or so, you’ve probably heard some media buzz about cell-based meat: animal tissue produced outside of an animal. But the pool of companies working in this space is actually pretty small in terms of product and geography.

Cellular aquacultured startup Shiok Meats is pushing the industry envelope on both accounts. Firstly, they’re developing ways to make cell-based crustaceans. Companies are working on ground beef, steak, pork sausages, salmon, and tuna — but as far as I’ve heard (and granted, some companies are in stealth mode), Shiok is the first to tackle crab, lobster, and shrimp.

When I spoke with Shiok Meats CEO and co-founder Dr. Sandhya Sriram, my first question was about texture. Replicating meat’s texture is one of the biggest challenges for cellular agriculture/aquaculture companies, and crustaceans in particular have a toothsome bite that seems like it would be much harder to copy than, say, ground beef or processed pork sausage. But Sriram is undaunted. “Yes, the technology and science are different [than other clean meat companies,] but we all have similar challenges,” she told me. They also won’t be trying to make the shell, which keeps things simpler. And with new innovations continuously being developed to facilitate cell growth, such as edible scaffolds, perhaps Shiok’s relatively late entrance will serve them well.

The fact that I could eventually taste a cell-based lobster roll is certainly exciting, but what’s more notable about Shiok Meats is its location. The startup is based in Singapore, which makes it, according to Sriram, the first cell-based meat company in Southeast Asia.

This is huge. Asia is the largest meat producer in the world, making 40-50 percent of the world’s meat. From a consumption perspective, there’s expected to be a 78 percent increase in demand for meat and seafood by year 2050. Yet the vast majority of cultured meat companies are based in the U.S. or, across the Atlantic, in the U.K. and Israel. (The notable exception is Shojinmeat, a Japanese company open sourcing clean meat production.) It makes sense that a company is bringing cell-based meat, which some herald as the solution to the evils of industrial meat consumption, to one of the regions where it could make the biggest impact.

But the choice to operate out of Singapore brings plenty of challenges. At the Alternative Protein Show this week in San Francisco, Sriram spoke about the differences between operating a cell-based meat company in the U.S. vs. Asia. Cultured meat companies in the U.S. have more access to funding and infrastructure than they would in Asia, and American and European consumers are more amenable to the concept of meat grown outside the animal.

Sriram told me that they expect to bring their first product to market in 3-5 years, with a taste test happening in the next year in high-end restaurants. Their target market is Asia-Pacific, so they’ll start rolling out products in Singapore, Hong Kong, and India, then eventually move onto Australia. Eventually, Shiok will sell their cell-based crustaceans to food companies who will incorporate their products into frozen meals.

For now, Shiok Meats is still in the R&D phase. They’ve developed a media (food which helps the animal cells grow) made of synthetic and plant-based substances, so they don’t have to use the very contentious Fetal Bovine Serum. They just closed their pre-seed round for an undisclosed amount and are working on raising a seed round over the next few months.

Currently, Shiok Meats just staffed by Sriram and her co-founder Ka Yi Ling. Compared to “veteran” cell-based meat companies like Memphis Meats, which was founded in 2015, the startup is small, young, and untested. But because of its location, Shiok Meats has the potential to make a global impact that could far outweigh cultured meat companies in the U.S. and Europe.

Primary Sidebar

Footer

  • About
  • Sponsor the Spoon
  • The Spoon Events
  • Spoon Plus

© 2016–2025 The Spoon. All rights reserved.

  • Facebook
  • Instagram
  • LinkedIn
  • RSS
  • Twitter
  • YouTube
 

Loading Comments...